European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients

Summary

The purpose of this Phase 3 study is to evaluate the efficacy and safety of 3APS as an add-on therapy to most standard medication for Alzheimer's disease compared to placebo (inactive substance pill) in patients with mild to moderate Alzheimer's disease.

Timeline

Start

2005-09

Primary completion

—

Completion

2007-12

Drugs

Indications